Holen Sie sich die Stockscreener-App
1.36
8.11%
-0.12
Handel nachbörslich:
1.36
Schlusskurs vom Vortag:
$1.48
Offen:
$1.47
24-Stunden-Volumen:
31,966
Relative Volume:
0.01
Marktkapitalisierung:
$10.67M
Einnahmen:
$598.00K
Nettoeinkommen (Verlust:
$-44.93M
KGV:
-0.1637
EPS:
-8.31
Netto-Cashflow:
$-17.32M
1W Leistung:
+3.03%
1M Leistung:
-15.53%
6M Leistung:
-42.62%
1J Leistung:
-68.71%
1-Tages-Spanne:
$1.3423
$1.47
1-Wochen-Bereich:
$1.22
$1.50
52-Wochen-Spanne:
$1.09
$14.40
Ernexa Therapeutics Inc Stock (ERNA) Company Profile
Firmenname
Ernexa Therapeutics Inc
Sektor
Branche
Telefon
(617) 798-6700
Adresse
1035 CAMBRIDGE STREET, CAMBRIDGE
Vergleichen Sie ERNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ERNA
Ernexa Therapeutics Inc
|
1.36 | 11.62M | 598.00K | -44.93M | -17.32M | -8.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ernexa Therapeutics Inc Aktie (ERNA) Neueste Nachrichten
Ernexa Therapeutics stock falls after ASH meeting presentation - Investing.com
Ernexa reports promising preclinical data for cancer cell therapy By Investing.com - Investing.com Australia
Ernexa Therapeutics stock falls after ASH meeting presentation By Investing.com - Investing.com Canada
Ernexa Therapeutics Presents New Preclinical Data on ERNA-101 at ASH Annual Meeting Highlighting Innovative Cell Therapy Potential to Combat Cancer - Quiver Quantitative
Ernexa reports promising preclinical data for cancer cell therapy - Investing.com
Ernexa Therapeutics Presents New Preclinical Data at - GlobeNewswire
Ernexa Therapeutics (ERNA) Stock Analysis Report | Financials & Insights - Benzinga
With Ernexa Therapeutics Stock Sliding, Have You Assessed The Risk? - Trefis
Can Ernexa Therapeutics Stock Recover If Markets Fall? - Trefis
Ernexa Therapeutics Inc. (ERNA) 5.2% in After-hours: Strong Presentation Initiative - Stocks Telegraph
Ernexa Therapeutics announces oral presentation at the 67th American Society of Hematology - marketscreener.com
Ernexa Therapeutics Announces Oral Presentation at the 67th American Society of Hematology (ASH) Annual Meeting - GlobeNewswire
Can Ernexa Therapeutics Inc. stock hit analyst price targetsWeekly Stock Recap & AI Powered Trade Plan Recommendations - Newser
How Ernexa Therapeutics Inc. stock compares to market leadersTrade Analysis Summary & Verified Stock Trade Ideas - Newser
Ernexa Therapeutics Strengthens Scientific and Medical Advisory Board with Appointment of Leading Oncologist Dr. Ira S. Winer, M.D., Ph.D., FACOG - markets.businessinsider.com
Ernexa Therapeutics appoints oncologist Dr. Winer to advisory board By Investing.com - Investing.com Australia
Ernexa Therapeutics appoints oncologist Dr. Winer to advisory board - Investing.com
Ernexa Therapeutics Appoints Dr. Ira S. Winer to Scientific and Medical Advisory Board - Quiver Quantitative
Ernexa Therapeutics Strengthens Scientific and Medical - GlobeNewswire
Profit Review: How Ernexa Therapeutics Inc. stock compares to industry benchmarks2025 Historical Comparison & Fast Moving Trade Plans - BỘ NỘI VỤ
Contrasting Ernexa Therapeutics (NASDAQ:ERNA) & KalVista Pharmaceuticals (NASDAQ:KALV) - Defense World
How Ernexa Therapeutics Inc. stock reacts to oil pricesJuly 2025 Action & Fast Momentum Stock Entry Tips - newser.com
How to monitor Ernexa Therapeutics Inc. with trend dashboardsTrade Entry Summary & Low Risk Entry Point Tips - newser.com
Ernexa Therapeutics Inc. stock chart pattern explained2025 Market Outlook & Verified Momentum Stock Alerts - newser.com
Sector ETF performance correlation with Ernexa Therapeutics Inc.Gap Down & Free AI Powered Buy and Sell Recommendations - newser.com
Is it too late to sell Ernexa Therapeutics Inc.Earnings Risk Report & AI Enhanced Trading Alerts - newser.com
Will Ernexa Therapeutics Inc. bounce back from current supportGold Moves & Real-Time Stock Entry Alerts - newser.com
Why Ernexa Therapeutics Inc. stock could see breakout soonTrend Reversal & Weekly Setup with High ROI Potential - newser.com
Analyzing drawdowns of Ernexa Therapeutics Inc. with statistical toolsGap Down & Long-Term Safe Investment Plans - newser.com
Will Ernexa Therapeutics Inc. stock benefit from automationEntry Point & AI Powered Buy/Sell Recommendations - newser.com
Should I hold or sell Ernexa Therapeutics Inc. stock in 2025Forecast Cut & Free Growth Oriented Trading Recommendations - newser.com
Why Ernexa Therapeutics Inc. stock is a value investor pickJuly 2025 WrapUp & High Accuracy Swing Trade Signals - Fundação Cultural do Pará
Finanzdaten der Ernexa Therapeutics Inc-Aktie (ERNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):